Answer
Stopping an antiplatelet prematurely after coronary intervention can increase the risk of stent thrombosis, heart attack or death from the underlying disease. Discuss interruption with the cardiology team.
Sources for this answer
- Prasugrel Mylan 10 mg Film-coated Tabletsemc · SmPC Current selected SmPC · Version 4